News New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance Staff September 11, 2023 Iframe sync Post navigation Previous: SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific OfficerNext: Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance More Stories Clinical Trial Healthcare News Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis Staff January 13, 2026 Healthcare News Pharmaceutical CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026 Staff January 12, 2026 Healthcare News TempraMed Closes C$2.5 Million Fully Subscribed Private Placement Staff January 12, 2026
